The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
about
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The QUIDAM study: Hydroquinidi ...... ients at high arrhythmic risk.
@en
type
label
The QUIDAM study: Hydroquinidi ...... ients at high arrhythmic risk.
@en
prefLabel
The QUIDAM study: Hydroquinidi ...... ients at high arrhythmic risk.
@en
P2093
P50
P1433
P1476
The QUIDAM study: Hydroquinidi ...... tients at high arrhythmic risk
@en
P2093
Antoine Andorin
Béatrice Delasalle
Didier Klug
Dominique Babuty
Frédéric Sacher
Hervé le Marec
Jacques Mansourati
Jean-Baptiste Gourraud
Jean-Claude Deharo
Jean-Marc Davy
P304
P356
10.1016/J.HRTHM.2017.04.019
P577
2017-04-12T00:00:00Z